Analysts Set Expectations for Teladoc Health Q1 Earnings

Teladoc Health, Inc. (NYSE:TDOC - Free Report) - Equities research analysts at William Blair issued their Q1 2026 earnings estimates for Teladoc Health in a research report issued on Wednesday, April 30th. William Blair analyst R. Daniels anticipates that the health services provider will post earnings of ($0.32) per share for the quarter. The consensus estimate for Teladoc Health's current full-year earnings is ($1.16) per share. William Blair also issued estimates for Teladoc Health's Q2 2026 earnings at ($0.18) EPS, Q3 2026 earnings at ($0.17) EPS and Q4 2026 earnings at ($0.17) EPS.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%.

A number of other equities analysts have also commented on TDOC. Evercore ISI dropped their price objective on Teladoc Health from $8.00 to $7.00 and set an "in-line" rating on the stock in a research note on Thursday, May 1st. The Goldman Sachs Group cut their price objective on Teladoc Health from $13.00 to $10.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Oppenheimer cut their price target on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a report on Friday, January 24th. Piper Sandler dropped their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a report on Thursday, February 27th. Finally, Canaccord Genuity Group reduced their target price on Teladoc Health from $14.00 to $12.00 and set a "buy" rating on the stock in a report on Thursday, May 1st. Eleven analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $9.81.

Teladoc Health Stock Performance

Shares of NYSE:TDOC traded up $0.03 during trading on Friday, reaching $6.81. The stock had a trading volume of 2,617,324 shares, compared to its average volume of 6,249,485. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock has a fifty day simple moving average of $7.89 and a two-hundred day simple moving average of $9.45. The firm has a market capitalization of $1.19 billion, a price-to-earnings ratio of -1.18 and a beta of 1.82. Teladoc Health has a 52 week low of $6.35 and a 52 week high of $15.21.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Robeco Institutional Asset Management B.V. raised its position in Teladoc Health by 21.8% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 700,166 shares of the health services provider's stock worth $6,365,000 after acquiring an additional 125,111 shares in the last quarter. Versant Capital Management Inc raised its stake in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider's stock valued at $29,000 after buying an additional 2,441 shares during the period. Nisa Investment Advisors LLC lifted its position in shares of Teladoc Health by 20,936.8% in the fourth quarter. Nisa Investment Advisors LLC now owns 426,206 shares of the health services provider's stock valued at $3,874,000 after buying an additional 424,180 shares during the last quarter. Charles Schwab Investment Management Inc. increased its holdings in shares of Teladoc Health by 18.7% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,443,713 shares of the health services provider's stock worth $22,213,000 after acquiring an additional 384,528 shares during the last quarter. Finally, Geode Capital Management LLC raised its stake in Teladoc Health by 0.6% in the 4th quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after acquiring an additional 22,664 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Adam C. Vandervoort sold 11,011 shares of the business's stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the sale, the insider now owns 64,308 shares of the company's stock, valued at $541,473.36. The trade was a 14.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 0.58% of the stock is currently owned by company insiders.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.